Clinical Studies
We lead or collaborate as strategic partners in various clinical studies, both interventional and observational, in the fields of Precision Nutrition and Precision Medicine.
Targeted metabolomics can identify unique metabolic profiles associated with specific diseases, enabling earlier and more accurate diagnoses — such as the identification of biomarkers for diabetes, cancer, cardiovascular, or neurodegenerative diseases.
It can also be used to predict disease progression and treatment response, or contribute to personalized medicine by identifying metabolites that predict the efficacy or toxicity of therapies in specific individuals.
Clinical Intervention Studies

Microbiome manipulation through Polyphenols for managing gut Leakiness in the Elderly (MaPLE)

Diet x gut microbiome-based metabotypes to determine cardio-metabolic risk and tailor intervention strategies for improved health (DiGuMet)

Tailored Carbohydrate Quality for Personalized Weight Management and Metabolic Health (Carb-Q-4-Health)

Influence of Anthocyanin metabotype after ingestion of grape/blueberry-extract over 4 weeks on cancer cell migration in-vitro (ATTACH)

Barcelona Brain Health Initiative (BBHI)

Cocoa polyphenols

PrediMED

Observational Studies

Barcelona Brain Health Initative (BBHI)

Toledo Study of Healthy Aging

InCHIANTI

Danish Cancer Society

EPIC-Europe: Cancer and Nutrition

CohorFES

Diet x gut microbiome-based metabotypes to determine cardio-metabolic risk and tailor intervention strategies for improved health (DiGuMet)

Tailored Carbohydrate Quality for Personalized Weight Management and Metabolic Health (Carb-Q-4-Health)
How can we help you?
Department of Nutrition, Food Science, and Gastronomy
Faculty of Pharmacy and Food Sciences, INSA-UB
University of Barcelona
Diagonal Campus, Avda. Joan XXIII, 27-31, Building B
08028 – Barcelona



